Positive results for Epic prostate cancer testing
/Blood Test Study Meets Goal, Validates Epic’s Prostate Cancer Target
Epic Sciences has commercialized a blood test that can predict how likely a patient with late-stage prostate cancer treated with hormones is likely to respond to an additional course of such therapy. Now, the San Diego-based company has additional data that it says supports use of its tests to determine when not to use hormone therapy
